GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Thoratec Corporation (THOR) [hlAlert]

Rating:
Buy THOR
up 192.91 %

Thoratec Corporation (THOR) rated Buy with price target $39 by Wedbush Morgan

Posted on: Thursday,  Mar 12, 2009  9:25 AM ET by Wedbush Morgan

Wedbush Morgan rated Buy Thoratec Corporation (NASDAQ: THOR) on 03/12/2009, when the stock price was $21.30. Since
then, Thoratec Corporation has gained 192.91% as of 08/27/2015's recent price of $62.39.
If you would have followed this Wedbush Morgan's recommendation on THOR, you would have gained 192.91% of your investment in 2359 days.

Thoratec Corporation (Thoratec) is a manufacturer of mechanical circulatory support products for use by patients with heart failure (HF). The Company develops, manufactures and markets medical devices used for circulatory support. It also develops, manufactures and markets point-of-care diagnostic test systems and skin incision products. Thoratec operates in two operating divisions: Cardiovascular and International Technidyne Corporation (ITC), a wholly owned subsidiary. The Cardiovascular segment develops, manufactures and markets medical devices used for mechanical circulatory support (MCS). ITC designs, develops, manufactures and markets point-of-care diagnostic test systems and incision products. The Company conducts business both in the United States and internationally.

Since 1980, WEDBUSH has used its private equity discipline to invest in under-valued and capital constrained public and private companies that have a significant potential for appreciation. The firm invests with high quality management teams with domain expertise and expects management to retain or make a personally significant equity investment.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/12/2009 9:25 AM Buy
None
21.30 39.00
as of 12/31/2009
1 Week down  -2.12 %
1 Month down  -11.71 %
3 Months down  -13.11 %
1 YTD up  23.47 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy